Brief: Anika Therapeutics Q2 Revenue USD 44.302 Million
08/08/2023 21:06
Aug 08 (Reuters) - Anika Therapeutics Q2 gross profit USD 28.972 million. * Q2 income from operations USD -3.631 million * Q2 net income USD -2.741 million * Q2 pretax profit USD -3.07 million